Elevated Expression of Moesin in Muscular Dystrophies.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  American Journal of Pathology

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ajpath.2016.11.013PMID 28082118
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistochemical assessment of ezrin and moesin in colorectal carcinoma

  2016cited by this paper
• Enhanced Muscular Dystrophy from Loss of Dysferlin Is Accompanied by Impaired Annexin A6 Translocation after Sarcolemmal Disruption.

  2016cited by this paper
• A glimpse of the ERM proteins

  2016cited by this paper
• Caspase Cleavages of the Lymphocyte-oriented Kinase Prevent Ezrin, Radixin, and Moesin Phosphorylation during Apoptosis*

  2016cited by this paper
• Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype

  2016cited by this paper
• Dynamic interplay between adhesion surfaces in carcinomas: Cell-cell and cell-matrix crosstalk.

  2016cited by this paper
• Connective tissue cells expressing fibro/adipogenic progenitor markers increase under chronic damage: relevance in fibroblast-myofibroblast differentiation and skeletal muscle fibrosis

  2016cited by this paper
• Urinary candidate biomarker discovery in a rat unilateral ureteral obstruction model

  2015cited by this paper
• Identification of anti-moesin antibodies in the serums of patients with antiphospholipid syndrome.

  2015cited by this paper
• Halofuginone — The Multifaceted Molecule

  2015cited by this paper
• Label‐free mass spectrometric analysis of the mdx‐4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy‐related fibrosis

  2015cited by this paper
• The ezrin-radixin-moesin family of proteins in the regulation of B-cell immune response.

  2015cited by this paper
• Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy

  2015cited by this paper
• Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract.

  2014cited by this paper
• G protein-coupled receptor kinase GRK5 phosphorylates moesin and regulates metastasis in prostate cancer.

  2014cited by this paper
• Moesin Expression in Fibrosis in the Mouse Cornea After Sterile Mechanical Trauma or Infection

  2014cited by this paper
• Halofuginone improves muscle-cell survival in muscular dystrophies.

  2014cited by this paper
• Role of Moesin in Renal Fibrosis

  2014cited by this paper
• Understanding the Process of Fibrosis in Duchenne Muscular Dystrophy

  2014cited by this paper
• Redundant control of migration and adhesion by ERM proteins in vascular smooth muscle cells.

  2013cited by this paper
• Muscular dystrophy in dysferlin-deficient mouse models.

  2013cited by this paper
• Ezrin, radixin, and moesin phosphorylation in NIH3T3 cells revealed angiotensin II type 1 receptor cell-type-dependent biased signaling.

  2013cited by this paper
• Phosphorylation of moesin by Jun N-terminal kinase is important for podosome rosette formation in Src-transformed fibroblasts

  2013cited by this paper
• The involvement of collagen triple helix repeat containing 1 in muscular dystrophies.

  2013cited by this paper
• Inhibition of muscle fibrosis and improvement of muscle histopathology in dysferlin knock-out mice treated with halofuginone.

  2013cited by this paper
• Function of Ezrin‐Radixin‐Moesin Proteins in Migration of Subventricular Zone‐Derived Neuroblasts Following Traumatic Brain Injury

  2013cited by this paper
• Wasting mechanisms in muscular dystrophy.

  2013cited by this paper
• RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response

  2012cited by this paper
• Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.

  2012cited by this paper
• Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD).

  2011cited by this paper
• Emerging role for ERM proteins in cell adhesion and migration

  2011cited by this paper
• Halofuginone and muscular dystrophy.

  2011cited by this paper
• Halofuginone inhibits Smad3 phosphorylation via the PI3K/Akt and MAPK/ERK pathways in muscle cells: effect on myotube fusion.

  2010cited by this paper
• Altered production of extra-cellular matrix components by muscle-derived Duchenne muscular dystrophy fibroblasts before and after TGF-β1 treatment

  2010cited by this paper
• Organizing the cell cortex: the role of ERM proteins

  2010cited by this paper
• Fibrosis inhibition and muscle histopathology improvement in laminin‐α2‐deficient mice

  2010cited by this paper
• Reverse Engineering Gene Network Identifies New Dysferlin-interacting Proteins

  2010cited by this paper
• Stem cell factor induces ERM proteins phosphorylation through PI3K activation to mediate melanocyte proliferation and migration

  2009cited by this paper
• Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice.

  2009cited by this paper
• Anti-moesin antibodies in the serum of patients with aplastic anemia stimulate peripheral blood mononuclear cells to secrete TNF-alpha and IFN-gamma.

  2009cited by this paper
• Tumor Necrosis Factor-α Regulates Transforming Growth Factor-β-dependent Epithelial-Mesenchymal Transition by Promoting Hyaluronan-CD44-Moesin Interaction*

  2009cited by this paper
• Endomysial Fibrosis in Duchenne Muscular Dystrophy: A Marker of Poor Outcome Associated With Macrophage Alternative Activation

  2009cited by this paper
• Moesin orchestrates cortical polarity of melanoma tumour cells to initiate 3D invasion

  2009cited by this paper
• Anti-Moesin Antibodies in the Serum of Patients with Aplastic Anemia Stimulate Peripheral Blood Mononuclear Cells to Secrete TNF-α and IFN-γ1

  2009cited by this paper
• Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone.

  2008cited by this paper
• Attenuated response to liver injury in moesin-deficient mice: impaired stellate cell migration and decreased fibrosis.

  2008cited by this paper
• Targeting TGFβ signaling to inhibit fibroblast activation as a therapy for fibrosis and cancer: effect of halofuginone

  2008cited by this paper
• Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy.

  2008cited by this paper
• Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states

  2007cited by this paper
• Molecular mechanisms of muscular dystrophies: old and new players

  2006cited by this paper
• Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-α2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?

  2006cited by this paper
• The Nck-interacting kinase phosphorylates ERM proteins for formation of lamellipodium by growth factors

  2006cited by this paper
• Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings.

  2004cited by this paper
• Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy.

  2004cited by this paper
• Muscular dystrophies: genes to pathogenesis.

  2003cited by this paper
• The Heart in Human Dystrophinopathies

  2003cited by this paper
• Platelet‐derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study

  2003cited by this paper
• Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

  2003cited by this paper
• Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle

  2002cited by this paper
• Fibrogenic cytokines and extent of fibrosis in muscle of dogs with X-linked golden retriever muscular dystrophy.

  2002cited by this paper
• Regenerated mdx mouse skeletal muscle shows differential mRNA expression.

  2002cited by this paper
• The muscular dystrophies.

  2002cited by this paper
• ERM proteins and merlin: integrators at the cell cortex

  2002cited by this paper
• Expression Profiling in the Muscular Dystrophies

  2000cited by this paper
• Pax7 is required for the specification of myogenic satellite cells.

  2000cited by this paper
• Expression Profiling in the Muscular Dystrophies Identification of Novel Aspects of Molecular Pathophysiology

  2000cited by this paper
• Clinical and Histopathological Study of Merosin-deficient and Merosin-positive Congenital Muscular Dystrophy

  2000cited by this paper
• Elevated plasma levels of transforming growth factor β1 in patients with muscular dystrophy

  2000cited by this paper
• Defective growth in vitro of Duchenne muscular dystrophy myoblasts: The molecular and biochemical basis

  1999cited by this paper
• Transforming growth factor‐β2 is elevated in skeletal muscle disorders

  1999cited by this paper
• Transforming growth factor-beta1 and fibrosis in congenital muscular dystrophies.

  1999cited by this paper
• Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine.

  1995cited by this paper
• O R I G I N a L I N V E S T I G a T I O N Open Access

  year unknowncited by this paper

• Tissue-Specific and NF-kappaB-Independent Xist RNA Localization Patterns in Female Intestinal, Blood, and Muscle Progenitors

  2025cites this paper
• Molecular composition of skeletal muscle in infants and adults: a comparative proteomic and transcriptomic study

  2024cites this paper
• Profiling of plasma extracellular vesicles identifies proteins that strongly associate with patient’s global assessment of disease activity in rheumatoid arthritis

  2024cites this paper
• Nuclear Factor Erythroid 2-Related Factor 2 and Its Targets in Skeletal Muscle Repair and Regeneration

  2023cites this paper
• Differential Effects of Halofuginone Enantiomers on Muscle Fibrosis and Histopathology in Duchenne Muscular Dystrophy

  2021cites this paper
• The role of Nrf2 in acute and chronic muscle injury

  2020cites this paper
• Interfering MSN-NONO complex–activated CREB signaling serves as a therapeutic strategy for triple-negative breast cancer

  2020cites this paper
• Stereoselective Intermolecular [4+2] Process of N ,O‐acetals with Terminal Alkynes for Construction of Functional cis ‐Pyrido and Pyrrolo[1,2‐c][1,3]oxazin‐1‐ones

  2020cites this paper
• Progress: Targeted Therapy, Immunotherapy, and New Chemotherapy Strategies in Advanced Triple-Negative Breast Cancer

  2020cites this paper
• CMAR_A_272685 9375..9387

  2020cites this paper
• Oligodendrocyte degeneration and concomitant 1 microglia activation directs peripheral immune cells into the forebrain 2 3

  2020cites this paper
• Two Sides of the Coin: Ezrin/Radixin/Moesin and Merlin Control Membrane Structure and Contact Inhibition

  2019cites this paper
• Oligodendrocyte degeneration and concomitant microglia activation directs peripheral immune cells into the forebrain

  2019cites this paper
• Nintedanib decreases muscle fibrosis and improves muscle function in a murine model of dystrophinopathy

  2018cites this paper
• A promotive effect for halofuginone on membrane repair and synaptotagmin-7 levels in muscle cells of dysferlin-null mice

  2018cites this paper
• Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer

  2018cites this paper